VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

Completed · Phase 1 · Has a placebo group

Conditions studied: Parkinson's Disease

In brief

The objective of this study is to assess the safety of VY-AADC02 in participants with Parkinson's disease (PD) with motor fluctuations.

Key facts

Study ID

NCT03562494

Run by

Neurocrine Biosciences

People needed

14

Starts

2018-10-17

Expected to finish

2024-10-30

Last updated by the study team

2024-12-10

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UC Irvine — Irvine, California, United States
• UC Davis Health System — Sacramento, California, United States
• University of California, San Francisco — San Francisco, California, United States
• University of Colorado — Aurora, Colorado, United States
• Emory University Hospital — Atlanta, Georgia, United States
• Northwestern Medical Faculty Foundation — Chicago, Illinois, United States
• University of Kansas Medical Center — Kansas City, Kansas, United States
• NYU Langone Medical Center — New York, New York, United States
• Ohio State University Clinical Trials Management Office — Columbus, Ohio, United States
• University of Philadelphia, Dept of Neurology — Philadelphia, Pennsylvania, United States
• University of Pittsburgh Medical Center (UPMC) — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.